glp 1 and gip combination GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica GIP and GLP‐1, the two

JAMA Psychiatry 82 (4), 395405

Overall, although the overall absolute risk increase is small (27 cases per 10,000 persons treated per year), clinical practitioners should nevertheless take into account the potential risk of gallbladder or biliary diseases associated with GLP-1RAs, especially when used at higher doses, for longer durations, and for weight loss, and in case the patient has a history of lithiasis [64]

Researchers are mapping how changes in gut bacterial composition, including those caused by GLP-1 agonists, ripple outward to affect urinary tract colonization patterns

This can contribute to better blood sugar control, especially in individuals with type 2 diabetes